STX-200s

N/A

Report date: 2025/03/20 15:15:20

Base Information

Drug NameSTX-200s
Drug Alias NameK-Ras GTPase modulator (Synthex Labs)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsPancreatic neuroendocrine tumors (pNET)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynthex Labs
China Registration ClassN/A

Develop Information

Active CompaniesSynthex Labs
Inactive CompaniesN/A
Active IndicationsPancreatic neuroendocrine tumors (pNET)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A